Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 6OTHER 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 1

Interventions

apatinib 4Etoposide 3surufatinib 2Topotecan 2Simvastatin 2Irinotecan 2Drug Therapy 2Carboplatin 2nintedanib 1camrelizumab 1anlotinib 1Tomography, X-Ray Computed 1Sunitinib 1Sorafenib 1Radiotherapy 1Paclitaxel 1PE regimen 1Lithium 1Immunotherapy 1Ifosfamide 1Gemcitabine 1EC regimen 1Cisplatin 1Breathing Exercises 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Small Cell Lung Carcinoma × EC regimen × Clear all
NCT06236997 2024-02-01

Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer

Henan Cancer Hospital

Phase 2 Not yet recruiting
48 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡